BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 21, 2011
 |  BC Week In Review  |  Company News  |  Deals

AmDerma Pharmaceuticals LLC, Oculus deal

Oculus granted AmDerma an option to license Oculus' Microcyn technology for $500,000 for a yet to be determined formulation to treat acne....

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >